companydata.dkcompanydata.dk

PHARMAZAN PHARMACEUTICALS ApS: Financial statements 2018

CVR: 32478697

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

PHARMAZAN PHARMACEUTICALS ApS (CVR 32478697) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 211,341 and a net result of DKK 211,199 compared with DKK 494,031 the year before. That is a decrease of 57.2% compared with the year before. Equity in the 2018 report amounted to DKK 133,222. The solvency ratio was 15.6%.

Gross Profit
DKK 211,341
Profit/Loss
DKK 211,199
Equity
DKK 133,222
Total Assets
DKK 856,054

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-211 t.211 t.133 t.-
2017-494 t.494 t.-78 t.-
2016-355 t.355 t.-572 t.-
2015-96 t.92 t.-927 t.-
2014-280 t.807 t.-1 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

PHARMAZAN PHARMACEUTICALS ApS: The 2017 annual report is outApr 18, 2018

PHARMAZAN PHARMACEUTICALS ApS has published its annual report for 2017. Gross profit came to DKK 494,031, and the net result was DKK 494,031.

About PHARMAZAN PHARMACEUTICALS ApS

PHARMAZAN PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Frederikssund, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jens Otto Tram. The company is owned by HELSEFARMA ApS and TRAM HOLDING ApS. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK -21,837 and a net result of DKK -21,837 compared with DKK -40,416 the year before. Equity in the 2025 report amounted to DKK -64,051.

Source: annual report 2025, Danish Business Authority